| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/24/2023 | 3.36% | Morgan Stanley | $5 → $4 | Maintains | Underweight |
| 08/12/2022 | 29.2% | Morgan Stanley | $10 → $5 | Downgrades | Overweight → Underweight |
| 08/11/2022 | 184.24% | BMO Capital | $19 → $11 | Maintains | Outperform |
| 08/11/2022 | 3.36% | Goldman Sachs | $5 → $4 | Maintains | Neutral |
| 07/15/2022 | 158.4% | Morgan Stanley | $15 → $10 | Maintains | Overweight |
| 06/17/2022 | 390.96% | BMO Capital | → $19 | Initiates Coverage On | → Outperform |
| 05/24/2022 | 287.6% | Morgan Stanley | $19 → $15 | Maintains | Overweight |
| 05/24/2022 | 106.72% | Goldman Sachs | $12 → $8 | Maintains | Neutral |
| 04/05/2022 | 390.96% | Morgan Stanley | $20 → $19 | Maintains | Overweight |
| 06/23/2021 | 856.07% | Morgan Stanley | → $37 | Initiates Coverage On | → Overweight |
| 06/22/2021 | 985.27% | Goldman Sachs | → $42 | Initiates Coverage On | → Buy |
| 06/22/2021 | 856.07% | Morgan Stanley | → $37 | Initiates Coverage On | → Overweight |
| 06/22/2021 | 804.39% | Jefferies | → $35 | Initiates Coverage On | → Buy |
What is the target price for Centessa Pharmaceuticals (CNTA)?
There is no price target for Centessa Pharmaceuticals
What is the most recent analyst rating for Centessa Pharmaceuticals (CNTA)?
There is no analyst for Centessa Pharmaceuticals
When is the next analyst rating going to be posted or updated for Centessa Pharmaceuticals (CNTA)?
There is no next analyst rating for Centessa Pharmaceuticals
Is the Analyst Rating Centessa Pharmaceuticals (CNTA) correct?
There is no next analyst rating for Centessa Pharmaceuticals